User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 6 results.
    • Journal article
    Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
    Murthy, Rashmi K Loi, Sherene Okines, Alicia Paplomata, Elisavet Hamilton, Erika Hurvitz, Sara A Lin, Nancy U Borges, Virginia Abramson, Vandana Anders, Carey Bedard, Philippe L Oliveira, Mafalda Jakobsen, Erik Bachelot, Thomas Shachar, Shlomit S Müller, Volkmar Braga, Sofia Duhoux, François[UCL] Greil, Richard Cameron, David Carey, Lisa A Curigliano, Giuseppe Gelmon, Karen Hortobagyi, Gabriel Krop, Ian Loibl, Sibylle Pegram, Mark Slamon, Dennis Palanca-Wessels, M Corinna Walker, Luke Feng, Wentao Winer, Eric P (2020) The New England journal of medicine — Vol. 382, no. 7, p. 597-609 (2020)
    • Journal article
    Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
    Wulf, Gerald G Altmann, Bettina Ziepert, Marita D'Amore, Francesco Held, Gerhard Greil, Richard Tournilhac, Olivier Relander, Thomas Viardot, Andreas Wilhelm, Martin Wilhelm, Christian Pezzutto, Antonio Zijlstra, Josee M Van Den Neste, Eric[UCL] Lugtenburg, Pieternella J Doorduijn, Jeanette K Gelder, Michel van van Imhoff, Gustaaf W Zettl, Florian Braulke, Friederike Nickelsen, Maike Glass, Bertram Rosenwald, Andreas Gaulard, Philippe Loeffler, Markus Pfreundschuh, Michael Schmitz, Norbert Trümper, Lorenz ACT-2 study investigators (2021) Leukemia — Vol. 35, no.1, p. 143-155 (2021)
    • Journal article
    A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.
    Kuemmel, Sherko Campone, Mario Loirat, Delphine Lopez, Rafael Lopez Beck, J Thaddeus De Laurentiis, Michelino Im, Seock-Ah Kim, Sung-Bae Kwong, Ava Steger, Guenther G Adelantado, Esther Zamora Duhoux, François[UCL] Greil, Richard Kuter, Irene Lu, Yen-Shen Tibau, Ariadna Özgüroğlu, Mustafa Scholz, Christian W Singer, Christian F Vega, Estela Wimberger, Pauline Zamagni, Claudio Couillebault, Xuan-Mai Fan, Liqiong Guerreiro, Nelson Mataraza, Jennifer Sand-Dejmek, Janna Chan, Arlene (2022) Clinical cancer research — Vol. 28, no. 1, p. 106-115 (2022)
    • Journal article
    Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial.
    Hites, Maya Lapique, Eva Larranaga Massonnaud, Clément R Belhadi, Drifa Jamard, Simon Goehringer, François Danion, François Reignier, Jean de Castro, Nathalie Garot, Denis Lacombe, Karine Tolsma, Violaine Faure, Emmanuel Malvy, Denis Staub, Thérèse Courjon, Johan Cazenave-Roblot, France Dyrhol Riise, Anne Ma Leturnier, Paul Martin-Blondel, Guillaume Roger, Claire Akinosoglou, Karolina Moing, Vincent Le Piroth, Lionel Sellier, Pierre Lescure, Xavier Trøseid, Marius Clevenbergh, Philippe Dalgard, Olav Gallien, Sébastien Gousseff, Marie Loubet, Paul Vardon-Bounes, Fanny Visée, Clotilde Belkhir, Leïla[UCL] Botelho-Nevers, Élisabeth Cabié, André Kotanidou, Anastasia Lanternier, Fanny Rouveix-Nordon, Elisabeth Silva, Susana Thiery, Guillaume Poignard, Pascal Carcelain, Guislaine Diallo, Alpha Mercier, Noémie Terzic, Vida Bouscambert-Duchamp, Maude Gaymard, Alexandre Trabaud, Mary-Anne Destras, Grégory Josset, Laurence Billard, Nicolas Han, Thi-Hong-Lien Guedj, Jérémie Couffin-Cadiergues, Sandrine Dechanet, Aline Delmas, Christelle Esperou, Hélène Fougerou-Leurent, Claire Mestre, Soizic Le Métois, Anabelle Noret, Marion Bally, Isabelle Dergan-Dylon, Sebastián Tubiana, Sarah Kalif, Ouifiya Bergaud, Nathalie Leveau, Benjamin Eustace, Joe Greil, Richard Hajdu, Edit Halanova, Monika Paiva, Jose-Artur Piekarska, Anna Rodriguez Baño, Jesus Tonby, Kristian Trojánek, Milan Tsiodras, Sotirios Unal, Serhat Burdet, Charles Costagliola, Dominique Yazdanpanah, Yazdan Peiffer-Smadja, Nathan Mentré, France Ader, Florence DisCoVeRy study group (2024) The Journal of infection — Vol. 88, no.3, p. 106120 (2024)
    • Journal article
    Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
    Ader, Florence Bouscambert-Duchamp, Maude Hites, Maya Peiffer-Smadja, Nathan Poissy, Julien Belhadi, Drifa Diallo, Alpha Lê, Minh-Patrick Peytavin, Gilles Staub, Thérèse Greil, Richard Guedj, Jérémie Paiva, Jose-Artur Costagliola, Dominique Yazdanpanah, Yazdan Burdet, Charles Mentré, France DisCoVeRy Study Group Belkhir, Leïla[UCL] (2022) The Lancet. Infectious diseases — Vol. 22, no. 2, p. 209-221 (2022)
    • Journal article
    Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
    Thieblemont, Catherine Tilly, Hervé Gomes da Silva, Maria Casasnovas, Rene-Olivier Fruchart, Christophe Morschhauser, Franck Haioun, Corinne Lazarovici, Julien Grosicka, Anida Perrot, Aurore Trotman, Judith Sebban, Catherine Caballero, Dolores Greil, Richard van Eygen, Koen Cohen, Amos M Gonzalez, Hugo Bouabdallah, Reda Oberic, Lucie Corront, Bernadette Choufi, Bachra Lopez-Guillermo, Armando Catalano, John Van Hoof, Achiel Briere, Josette Cabeçadas, Jose Salles, Gilles Gaulard, Philippe Bosly, André[UCL] Coiffier, Bertrand (2017) Journal of Clinical Oncology — Vol. 35, no. 22, p. 2473-2481 (2017)